Morocco pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$101.8 million | 87.6% |
| 3002 Human blood | US$11.0 million | 9.4% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$1.9 million | 1.6% |
| 3003 Medicaments | US$1.4 million | 1.2% |
| 3006 Pharmaceutical goods | US$235,000 | 0.2% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$8,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$62.4 million | 53.7% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$16.6 million | 14.3% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$7.7 million | 6.6% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$6.6 million | 5.7% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$5.6 million | 4.8% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$5.5 million | 4.7% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$3.6 million | 3.1% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$3.3 million | 2.8% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$1.8 million | 1.5% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$989,000 | 0.9% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$622.3 million | 61.3% |
| 3002 Human blood | US$293.7 million | 28.9% |
| 3003 Medicaments | US$42.8 million | 4.2% |
| 3006 Pharmaceutical goods | US$38.5 million | 3.8% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$13.2 million | 1.3% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$4.5 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$473.8 million | 46.7% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$220.8 million | 21.8% |
| 300220 Vaccines: for human medicine | US$43.2 million | 4.3% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$41.5 million | 4.1% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$34.6 million | 3.4% |
| 300310 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | US$26.3 million | 2.6% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$23.5 million | 2.3% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$22.5 million | 2.2% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$20.0 million | 2.0% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$14.5 million | 1.4% |
Shares are of Morocco's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Morocco's trade.
More Morocco products
- 27 Mineral fuels, mineral oils and products of their distillation
- 85 Electrical machinery and equipment and parts thereof
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 31 Fertilizers
- 62 Apparel and clothing accessories
- 39 Plastics and articles thereof
- 88 Aircraft, spacecraft, and parts thereof
- 08 Fruit and nuts, edible
- 10 Cereals
- 07 Vegetables and certain roots and tubers
- 28 Inorganic chemicals
Morocco pharmaceutical products: questions and answers
How much pharmaceutical products does Morocco export?
In 2024, Morocco exported US$116.3 million of pharmaceutical products (HS chapter 30), 0.2% of its total exports. That ranks it 73 of 213 exporting countries in the data.
What are Morocco's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$101.8 million), Human blood (3002, US$11.0 million), Wadding, gauze, bandages (dressings, adhesive plasters… (3005, US$1.9 million).
How much pharmaceutical products does Morocco import?
In 2024, Morocco imported US$1.0 billion of pharmaceutical products (HS chapter 30), 1.1% of its total imports. That ranks it 67 of 226 importing countries in the data.
What are Morocco's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$622.3 million), Human blood (3002, US$293.7 million), Medicaments (3003, US$42.8 million).
